New review suggests metabolic pathways in ovarian cancer need better tools to treat

Ovarian cancer is a serious disease that often returns after initial treatment. A new narrative review explores how the cancer uses energy to survive and grow. The authors suggest that focusing on glycolysis, a specific way cells make energy, could help design better treatments. However, the current understanding is incomplete. The review points out that the cancer can switch to other energy paths when blocked. This makes it hard to stop the disease with just one drug. Without enough data on specific markers, doctors cannot easily pick the right combination of therapies for each person. The study notes that we lack sufficient clinical validation for these new ideas. This means we cannot yet say these strategies will work in real hospitals. The authors warn that metabolic differences between patients complicate the picture. We need more proof before we can trust these approaches to save lives.